Heron Therapeutics Inc (NASDAQ:HRTX) currently has a daily average trading volume of 1.69M but it saw 931076 shares traded in last market. With a market cap of 279.19M USD, the company’s current market price of $1.83 came falling about -3.17 while comparing to the previous closing price of $1.89. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.93 and as low as $1.04. In the recent trading on the day, stock has struck highest price mark of $1.83 while lowest mark touched by it was $1.88.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Rodman & Renshaw which initiated the stock as “Buy” in its note to investors issued on June 13, 2024, recommending a price target of $7 for it. Needham issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $4 and $5.
Over the week, HRTX’s stock price is moving -4.69% down while it is -21.46% when we observe its performance for the past one month. Year-to-date it is 19.61% up and over the past year, the stock is showing a downside performance of -47.26%.
Currently, Heron Therapeutics Inc’s total number of outstanding shares is 152.43M with 0.67% of that held by the insiders while 82.32% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -5.31%. It has a 22.88 of forward P/E ratio. Stock’s beta reads 1.16. Stock has a price to sale or P/S ratio amounts to 1.88. Its return on asset (ROA) is -3.43% on average.
